AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 78 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 13.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $562,000 | -47.1% | 669,449 | -30.1% | 0.03% | -58.2% |
| Q3 2014 | $1,063,000 | -51.6% | 958,026 | -20.2% | 0.08% | -51.8% |
| Q2 2014 | $2,197,000 | -48.6% | 1,200,800 | -58.0% | 0.16% | -7.3% |
| Q1 2014 | $4,274,000 | +63.4% | 2,858,348 | +100.0% | 0.18% | -27.5% |
| Q4 2013 | $2,615,000 | -63.8% | 1,429,174 | -59.3% | 0.24% | -67.8% |
| Q3 2013 | $7,229,000 | -17.6% | 3,509,205 | 0.0% | 0.76% | -26.8% |
| Q2 2013 | $8,773,000 | – | 3,509,205 | – | 1.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greylock XI GP Limited Partnership | 584,004 | $1,068,000 | 100.00% |
| GREAT POINT PARTNERS LLC | 2,325,000 | $4,255,000 | 1.89% |
| Sarissa Capital Management LP | 2,570,759 | $4,704,000 | 1.60% |
| Deer VI & Co. LLC | 675,242 | $1,236,000 | 0.68% |
| Palo Alto Investors LP | 1,200,800 | $2,197,000 | 0.16% |
| Baupost Group | 3,829,350 | $7,008,000 | 0.11% |
| Gruss Capital Management LP | 533,253 | $976,000 | 0.05% |
| Granahan Investment Management | 676,451 | $1,238,000 | 0.04% |
| Fore Research & Management, LP | 674,200 | $1,233,000 | 0.04% |
| TFS CAPITAL LLC | 210,369 | $385,000 | 0.03% |